Pfizer Inc.
Diacylglycerol acyl transferase 2 inhibitors
Last updated:
Abstract:
Compounds of Formula I that inhibit the activity of the diacylglycerol acyltransferase 2 (DGAT2) and their uses in the treatment of diseases linked thereto in animals are described herein.
Status:
Grant
Type:
Utility
Filling date:
18 Feb 2020
Issue date:
15 Jun 2021